Cardinal Health, Inc.
Healthcare Distribution / Medical DistributionFounded 1971- Updated July 2025
Reviewed by Swet Parvadiya
Last reviewed: July 2025
CorpDigest
Cardinal Health, Inc.
Company History
Founded 1971 in Dublin, Ohio, United States
Last reviewed: 2025-07-15 · By Swet Parvadiya
Cardinal Health, Inc. is absorbing the loss of a $38.1 billion customer contract—17% of its annual revenue—while simultaneously raising its fiscal 2026 earnings guidance and acquiring four specialty care platforms in oncology, gastroenterology, diabetes, and urology, demonstrating that a 1% margin pharmaceutical distribution business can generate substantial strategic optionality when operated at $222 billion in annual scale. The company's fiscal 2025 results showed the resilience of this model: revenues declined 2% to $222.6 billion but non-GAAP operating earnings rose 15% to $2.8 billion and non-GAAP EPS increased 9% to $8.24, as the expiration of low-margin OptumRx contracts improved overall profitability. With a market capitalization of approximately $48.2 billion, the company trades at just 0.22x sales—a valuation that reflects the commodity nature of distribution but may undervalue the emerging specialty services platform.
Robert D. Walter is the founder of Cardinal Health, Inc., establishing the company in 1971 as Cardinal Foods, a food wholesaler serving central Ohio and the Midwest. Born in Columbus, Ohio, in 1945, Walter graduated summa cum laude from Ohio State University and earned an MBA from Harvard Business School. After a brief, unsatisfying stint as an engineer at North American Rockwell, Walter decided to acquire and rehabilitate a mismanaged company in a simple line of business. He returned to Columbus, borrowed $1.3 million, and acquired Consolidated Foods' distribution division in a leveraged buyout. By 1980, he had grown Cardinal Foods tenfold but reached a strategic dead end in the consolidating food distribution industry. Walter pivoted to pharmaceutical distribution in 1979 with the acquisition of Bailey Drug Co. in Zanesville, Ohio, and executed a rapid series of acquisitions throughout the 1980s. He took the company public in 1983 and changed its name to Cardinal Health in 1994. Under his leadership as CEO through 2004, Cardinal grew from a small food distributor into a $50+ billion healthcare conglomerate through dozens of strategic acquisitions. Walter was known as a superb deal-maker who 'sneaked up' on competition and carefully avoided the pitfalls of big-company culture. He received an honorary doctorate from Ohio University in 1997 and the Christopher Columbus Award from the Greater Columbus Chamber of Commerce in 2001.
Robert D. Walter, a 26-year-old Harvard MBA graduate, borrowed $1.3 million to acquire the food-distribution division of Consolidated Foods in a leveraged buyout, establishing Cardinal Foods in Columbus, Ohio. The company was named after Ohio's state bird, the cardinal.
Walter acquired Bailey Drug Co., a pharmaceutical distributor in Zanesville, Ohio, marking Cardinal's entry into pharmaceutical distribution. This pivot was driven by the stagnation of the food distribution business and the rapid growth of pharmaceutical wholesaling.
Cardinal Distribution Inc. completed its initial public offering on the NASDAQ at $1.03 per share, providing capital for continued expansion through acquisitions. The IPO established the foundation for the company's growth from a regional distributor to a national healthcare enterprise.
Cardinal acquired Ellicott Drug, a pharmaceutical distributor in Buffalo, New York, continuing the acquisition-driven expansion strategy that would define the company's growth for decades.
Cardinal sold its remaining food operations to Roundy's Inc., completing the company's transition from a diversified food and drug distributor to a pure-play pharmaceutical distribution company. By this point, Cardinal was the third-largest pharmaceutical wholesaler in the United States.
The company changed its name from Cardinal Distribution to Cardinal Health, reflecting its expanding mission beyond pure distribution into healthcare services, manufacturing, and technology. Revenues exceeded $1 billion by 1991.
Cardinal acquired Medicine Shoppe International, the country's largest franchise of retail pharmacies, marking the company's first significant non-distribution acquisition and entry into retail pharmacy.
Cardinal acquired Pyxis Corp., a manufacturer of automated supply and pharmaceutical dispensing systems for hospitals, adding medical technology capabilities to the company's portfolio.
Cardinal acquired Allegiance Healthcare Corp. for approximately $4.4 billion, becoming a major player in the medical-surgical products market and establishing the foundation for what would become the Global Medical Products and Distribution segment.
Cardinal Health and CVS Caremark announced the creation of Red Oak Sourcing, a 50/50 joint venture to form the largest generic pharmaceutical sourcing entity in the United States. The venture began operations in July 2014 with an initial 10-year term.
Cardinal Health lost a major pharmaceutical distribution contract with Walgreens, which shifted its distribution to AmerisourceBergen. The contract had generated $3.3 billion in quarterly revenue. This loss demonstrated the customer concentration risk inherent in pharmaceutical wholesale.
Cardinal Health acquired the Patient Recovery business from Medtronic for $6.1 billion, expanding its medical products portfolio and adding significant scale to the Global Medical Products and Distribution segment.
Cardinal Health announced that its pharmaceutical distribution contracts with OptumRx (UnitedHealth Group's pharmacy benefits subsidiary) would not be renewed upon expiration in June 2024. OptumRx had generated approximately 17% of fiscal 2024 revenue ($38.1 billion), representing one of the largest customer losses in pharmaceutical wholesale history.
Despite the OptumRx revenue headwind, Cardinal Health reported fiscal 2025 revenues of $222.6 billion, GAAP operating earnings of $2.3 billion (up 83%), and net earnings of $1.6 billion (up 83%). The company raised fiscal 2026 non-GAAP EPS guidance to $9.30-$9.50 and announced the acquisition of Solaris Health, the country's leading urology MSO.
Cardinal Health's first acquisition in pharmaceutical distribution, marking the company's pivot from food wholesaling to healthcare. Bailey Drug was a small pharmaceutical distributor in Zanesville, Ohio.
Cardinal Health acquired Allegiance Healthcare to become a major player in the medical-surgical products market, adding manufacturing and distribution capabilities for medical and surgical supplies.
Cardinal Health acquired the Patient Recovery business from Medtronic to expand its medical products portfolio, adding wound care, compression therapy, and patient positioning products.
Cardinal Health acquired ADSG, a leading provider of diabetes supplies and services, to expand its at-Home Solutions business and capitalize on the growing direct-to-patient medical supplies market. ADSG serves approximately 500,000 patients annually.
Cardinal Health acquired ION, a network of community oncology practices, to build its specialty care platform in oncology and create integrated care networks combining drug distribution with practice management.
Cardinal Health acquired a 71% stake in GI Alliance, the largest gastroenterology practice management organization in the United States, to expand its specialty care platform into gastroenterology.